216 related articles for article (PubMed ID: 6624666)
1. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability.
Oetgen WJ; Tibbits PA; Abt ME; Goldstein RE
Am J Cardiol; 1983 Oct; 52(7):746-50. PubMed ID: 6624666
[TBL] [Abstract][Full Text] [Related]
2. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
5. Flecainide: long-term treatment using a reduced dosing schedule.
Flowers D; O'Gallagher D; Torres V; Miura D; Somberg JC
Am J Cardiol; 1985 Jan; 55(1):79-83. PubMed ID: 3966401
[TBL] [Abstract][Full Text] [Related]
6. Treatment of resistant ventricular tachycardia with flecainide acetate. Flecainide Ventricular Tachycardia Study Group.
Am J Cardiol; 1986 Jun; 57(15):1299-304. PubMed ID: 3717029
[TBL] [Abstract][Full Text] [Related]
7. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ
Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656
[TBL] [Abstract][Full Text] [Related]
8. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME
Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327
[TBL] [Abstract][Full Text] [Related]
9. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.
Connolly SJ; Kates RE; Lebsack CS; Echt DS; Mason JW; Winkle RA
Am J Cardiol; 1983 Dec; 52(10):1208-13. PubMed ID: 6359849
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
[TBL] [Abstract][Full Text] [Related]
12. [Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia].
Breithardt G; Borggrefe M; Yeh HL; Seipel L
Z Kardiol; 1982 Apr; 71(4):278-83. PubMed ID: 7090468
[TBL] [Abstract][Full Text] [Related]
13. Experience with electrophysiologically guided therapy of ventricular tachycardia with flecainide: summary of long-term follow-up.
Anderson JL
Am J Cardiol; 1984 Feb; 53(5):79B-86B. PubMed ID: 6695820
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
[TBL] [Abstract][Full Text] [Related]
15. [Estimation of the long-term efficacy of anti-arrhythmia treatment with flecainide in ventricular tachycardia].
Fauchier JP; Cosnay P; Babuty B; Moquet B; Rouesnel P; Estepo J
Arch Mal Coeur Vaiss; 1990 Jan; 83(1):77-83. PubMed ID: 2106308
[TBL] [Abstract][Full Text] [Related]
16. Bepridil for recurrent sustained ventricular tachycardias: assessment using electrophysiologic testing.
Levy S; Cointe R; Metge M; Faugere G; Valeix B; Gerard R
Am J Cardiol; 1984 Sep; 54(6):579-81. PubMed ID: 6332516
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous and oral flecainide on ventricular tachycardia.
Ward DE; Cheesman M; Dancy M
Int J Cardiol; 1986 Mar; 10(3):251-62. PubMed ID: 3957470
[TBL] [Abstract][Full Text] [Related]
18. [Electrophysiological anti-arrhythmia effects of tiracizine in ventricular tachycardia].
Volkmann H; Kühnert H; Dannberg G; Heinke M; Leeder U; Popp U
Z Gesamte Inn Med; 1991 Dec; 46(17):635-41. PubMed ID: 1776306
[TBL] [Abstract][Full Text] [Related]
19. Clinical and electrophysiologic effects of flecainide in patients with refractory ventricular tachycardia.
Capparelli EV; Kluger J; Regnier JC; Chow MS
J Clin Pharmacol; 1988 Mar; 28(3):268-75. PubMed ID: 3129456
[TBL] [Abstract][Full Text] [Related]
20. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.
Rothbart ST; Saksena S
Am J Cardiol; 1986 Apr; 57(11):941-6. PubMed ID: 3515898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
